SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-282499
Filing Date
2019-11-04
Accepted
2019-11-04 07:11:10
Documents
12
Period of Report
2019-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d830313d8k.htm   iXBRL 8-K 49252
  Complete submission text file 0001193125-19-282499.txt   175045

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA epzm-20191101.xsd EX-101.SCH 3067
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20191101_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20191101_pre.xml EX-101.PRE 10951
8 EXTRACTED XBRL INSTANCE DOCUMENT d830313d8k_htm.xml XML 3218
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 191188237
SIC: 2834 Pharmaceutical Preparations